Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 21 of 21 entries
Sorted by: Best Match Show Resources per page
Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration.

Journal of ophthalmic & vision research

Totan Y, Koca C, Erdurmuş M, Keskin U, Yiğitoğlu R.
PMID: 26425317
J Ophthalmic Vis Res. 2015 Apr-Jun;10(2):151-4. doi: 10.4103/2008-322X.163765.

PURPOSE: To evaluate plasma levels of endothelin-1 (ET-1) and nitric oxide (NO) in patients with exudative age-related macular degeneration (AMD).METHODS: In this study, ET-1 levels, as well as nitrite plus nitrate concentrations as an indicator of plasma NO level,...

Cite
Totan Y, Koca C, Erdurmuş M, et al. Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration. J Ophthalmic Vis Res. 2015;10(2):151-4doi: 10.4103/2008-322X.163765.
Totan, Y., Koca, C., Erdurmuş, M., Keskin, U., & Yiğitoğlu, R. (2015). Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration. Journal of ophthalmic & vision research, 10(2), 151-4. https://doi.org/10.4103/2008-322X.163765
Totan, Yϋksel, et al. "Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration." Journal of ophthalmic & vision research vol. 10,2 (2015): 151-4. doi: https://doi.org/10.4103/2008-322X.163765
Totan Y, Koca C, Erdurmuş M, Keskin U, Yiğitoğlu R. Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration. J Ophthalmic Vis Res. 2015 Apr-Jun;10(2):151-4. doi: 10.4103/2008-322X.163765. PMID: 26425317; PMCID: PMC4568612.
Copy Download .nbib Format: NLM
Investigation of the Utility and Safety of Dynamic Computed Tomography with Vasodilators.

Yonago acta medica

Watanabe J, Endo K, Tanaka Y, Goto K, Urushibara S, Osaki T, Tatebe S, Nakamura S, Hirooka Y, Ikeguchi M.
PMID: 32158333
Yonago Acta Med. 2020 Jan 24;63(1):47-54. doi: 10.33160/yam.2020.02.007. eCollection 2020 Feb.

BACKGROUND: Dynamic computed tomography (CT) angiography is useful for evaluating of hepatic vascularity. Although vasodilators increase hepatic blood flow, the utility of dynamic CT with vasodilators is unclear. Here we investigated the utility and safety of dynamic CT with...

Cite
Watanabe J, Endo K, Tanaka Y, et al. Investigation of the Utility and Safety of Dynamic Computed Tomography with Vasodilators. Yonago Acta Med. 2020;63(1):47-54doi: 10.33160/yam.2020.02.007.
Watanabe, J., Endo, K., Tanaka, Y., Goto, K., Urushibara, S., Osaki, T., Tatebe, S., Nakamura, S., Hirooka, Y., & Ikeguchi, M. (2020). Investigation of the Utility and Safety of Dynamic Computed Tomography with Vasodilators. Yonago acta medica, 63(1), 47-54. https://doi.org/10.33160/yam.2020.02.007
Watanabe, Jun, et al. "Investigation of the Utility and Safety of Dynamic Computed Tomography with Vasodilators." Yonago acta medica vol. 63,1 (2020): 47-54. doi: https://doi.org/10.33160/yam.2020.02.007
Watanabe J, Endo K, Tanaka Y, Goto K, Urushibara S, Osaki T, Tatebe S, Nakamura S, Hirooka Y, Ikeguchi M. Investigation of the Utility and Safety of Dynamic Computed Tomography with Vasodilators. Yonago Acta Med. 2020 Jan 24;63(1):47-54. doi: 10.33160/yam.2020.02.007. eCollection 2020 Feb. PMID: 32158333; PMCID: PMC7028539.
Copy Download .nbib Format: NLM
Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used.

European cardiology

Castillo PD, Casanovas N, Santaló M, Narro F, Caresia AP, Barradas A, Bragagnini W, Martin JC, Guillamon L, Bernà L, Martínez-Rubio A.
PMID: 30416572
Eur Cardiol. 2017 Dec;12(2):102. doi: 10.15420/ecr.2017:23:11.

No abstract available.

Cite
Castillo PD, Casanovas N, Santaló M, et al. Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used. Eur Cardiol. 2017;12(2):102doi: 10.15420/ecr.2017:23:11.
Castillo, P. D., Casanovas, N., Santaló, M., Narro, F., Caresia, A. P., Barradas, A., Bragagnini, W., Martin, J. C., Guillamon, L., Bernà, L., & Martínez-Rubio, A. (2017). Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used. European cardiology, 12(2), 102. https://doi.org/10.15420/ecr.2017:23:11
Castillo, Pablo Del, et al. "Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used." European cardiology vol. 12,2 (2017): 102. doi: https://doi.org/10.15420/ecr.2017:23:11
Castillo PD, Casanovas N, Santaló M, Narro F, Caresia AP, Barradas A, Bragagnini W, Martin JC, Guillamon L, Bernà L, Martínez-Rubio A. Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used. Eur Cardiol. 2017 Dec;12(2):102. doi: 10.15420/ecr.2017:23:11. PMID: 30416572; PMCID: PMC6213215.
Copy Download .nbib Format: NLM
Perspectives in the treatment of vascular dementia.

Drugs of today (Barcelona, Spain : 1998)

Romàn G.
PMID: 12847569
Drugs Today (Barc). 2000 Sep;36(9):641-53. doi: 10.1358/dot.2000.36.9.593781.

The diagnosis and treatment of vascular dementia (VaD) are particularly challenging because of its multiple causal lesions and the variety of its clinical presentations. Even poststroke dementia cases may be due to preexisting Alzheimer's disease. Diagnostic criteria for clinical...

Cite
Romàn G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000;36(9):641-53doi: 10.1358/dot.2000.36.9.593781.
Romàn, G. (2000). Perspectives in the treatment of vascular dementia. Drugs of today (Barcelona, Spain : 1998), 36(9), 641-53. https://doi.org/10.1358/dot.2000.36.9.593781
Romàn, G. "Perspectives in the treatment of vascular dementia." Drugs of today (Barcelona, Spain : 1998) vol. 36,9 (2000): 641-53. doi: https://doi.org/10.1358/dot.2000.36.9.593781
Romàn G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000 Sep;36(9):641-53. doi: 10.1358/dot.2000.36.9.593781. PMID: 12847569.
Copy Download .nbib Format: NLM
Vasoactive drug use in septic shock.

Seminars in respiratory and critical care medicine

Stanchina ML, Levy MM.
PMID: 16088509
Semin Respir Crit Care Med. 2004 Dec;25(6):673-81. doi: 10.1055/s-2004-860981.

Sepsis accounts for more than 210,000 deaths per year. Despite adequate fluid resuscitation the associated maldistribution of blood flow may cause an imbalance between oxygen delivery and demand, leading to global tissue hypoxia, shock, and, if not reversed, death....

Cite
Stanchina ML, Levy MM. Vasoactive drug use in septic shock. Semin Respir Crit Care Med. 2004;25(6):673-81doi: 10.1055/s-2004-860981.
Stanchina, M. L., & Levy, M. M. (2004). Vasoactive drug use in septic shock. Seminars in respiratory and critical care medicine, 25(6), 673-81. https://doi.org/10.1055/s-2004-860981
Stanchina, Michael L, and Levy, Mitchell M. "Vasoactive drug use in septic shock." Seminars in respiratory and critical care medicine vol. 25,6 (2004): 673-81. doi: https://doi.org/10.1055/s-2004-860981
Stanchina ML, Levy MM. Vasoactive drug use in septic shock. Semin Respir Crit Care Med. 2004 Dec;25(6):673-81. doi: 10.1055/s-2004-860981. PMID: 16088509.
Copy Download .nbib Format: NLM
Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?.

JRSM cardiovascular disease

Assaad M, Berry A, Palanisamy J, Fenner J, Zughaib M.
PMID: 30792855
JRSM Cardiovasc Dis. 2019 Feb 10;8:2048004019828257. doi: 10.1177/2048004019828257. eCollection 2019.

BACKGROUND: Myocardial perfusion imaging (MPI) stress test is performed either using exercise as a stress modality or through the use of pharmacological vasodilator agents in those who cannot exercise. Regadenoson and dipyridamole are some of the most common vasodilator...

Cite
Assaad M, Berry A, Palanisamy J, et al. Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?. JRSM Cardiovasc Dis. 2019;8:2048004019828257doi: 10.1177/2048004019828257.
Assaad, M., Berry, A., Palanisamy, J., Fenner, J., & Zughaib, M. (2019). Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?. JRSM cardiovascular disease, 82048004019828257. https://doi.org/10.1177/2048004019828257
Assaad, Mahmoud, et al. "Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?." JRSM cardiovascular disease vol. 8 (2019): 2048004019828257. doi: https://doi.org/10.1177/2048004019828257
Assaad M, Berry A, Palanisamy J, Fenner J, Zughaib M. Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?. JRSM Cardiovasc Dis. 2019 Feb 10;8:2048004019828257. doi: 10.1177/2048004019828257. eCollection 2019. PMID: 30792855; PMCID: PMC6376496.
Copy Download .nbib Format: NLM
Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels.

Future medicinal chemistry

Munín J, Quezada E, Viña D, Uriarte E, Delogu GL, Gil-Longo J.
PMID: 30801201
Future Med Chem. 2019 Feb 25; doi: 10.4155/fmc-2018-0250. Epub 2019 Feb 25.

AIM: Hydralazine has led to the synthesis of phthalazinone derivatives which induce vasorelaxation.METHODS: A new series of 2-(aminoalkyl)-4-benzyl-2H-phthalazin-1-one derivatives has been synthesized to study their vasorelaxant activity.RESULTS: At the highest-studied concentration, most of the new compounds relaxed the denuded...

Cite
Munín J, Quezada E, Viña D, et al. Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels. Future Med Chem. 2019;doi: 10.4155/fmc-2018-0250.
Munín, J., Quezada, E., Viña, D., Uriarte, E., Delogu, G. L., & Gil-Longo, J. (2019). Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels. Future medicinal chemistry, . https://doi.org/10.4155/fmc-2018-0250
Munín, Javier, et al. "Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels." Future medicinal chemistry vol. (2019). doi: https://doi.org/10.4155/fmc-2018-0250
Munín J, Quezada E, Viña D, Uriarte E, Delogu GL, Gil-Longo J. Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels. Future Med Chem. 2019 Feb 25; doi: 10.4155/fmc-2018-0250. Epub 2019 Feb 25. PMID: 30801201.
Copy Download .nbib Format: NLM
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension.

Pulmonary circulation

Barst RJ, Channick R, Ivy D, Goldstein B.
PMID: 22837854
Pulm Circ. 2012 Apr-Jun;2(2):139-47. doi: 10.4103/2045-8932.97589.

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary vasculature with a high morbidity and mortality. Its pathobiology involves at least three interacting pathways - prostacyclin (PGI(2)), endothelin, and nitric oxide (NO). Current treatments target these...

Cite
Barst RJ, Channick R, Ivy D, et al. Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulm Circ. 2012;2(2):139-47doi: 10.4103/2045-8932.97589.
Barst, R. J., Channick, R., Ivy, D., & Goldstein, B. (2012). Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulmonary circulation, 2(2), 139-47. https://doi.org/10.4103/2045-8932.97589
Barst, Robyn J, et al. "Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension." Pulmonary circulation vol. 2,2 (2012): 139-47. doi: https://doi.org/10.4103/2045-8932.97589
Barst RJ, Channick R, Ivy D, Goldstein B. Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulm Circ. 2012 Apr-Jun;2(2):139-47. doi: 10.4103/2045-8932.97589. PMID: 22837854; PMCID: PMC3401867.
Copy Download .nbib Format: NLM
Miscellaneous pharmaceutical agents in interventional radiology.

Seminars in interventional radiology

Oppenheimer J, Ray CE, Kondo KL.
PMID: 22550384
Semin Intervent Radiol. 2010 Dec;27(4):422-30. doi: 10.1055/s-0030-1267854.

Interventional radiologists employ a wide variety of drugs on a daily basis to improve patient experiences and outcomes during interventional procedures. The expectation is for the interventionalist to be well-versed in all pharmaceuticals used in the interventional suite. In...

Cite
Oppenheimer J, Ray CE, Kondo KL. Miscellaneous pharmaceutical agents in interventional radiology. Semin Intervent Radiol. 2010;27(4):422-30doi: 10.1055/s-0030-1267854.
Oppenheimer, J., Ray, C. E., & Kondo, K. L. (2010). Miscellaneous pharmaceutical agents in interventional radiology. Seminars in interventional radiology, 27(4), 422-30. https://doi.org/10.1055/s-0030-1267854
Oppenheimer, Jason, et al. "Miscellaneous pharmaceutical agents in interventional radiology." Seminars in interventional radiology vol. 27,4 (2010): 422-30. doi: https://doi.org/10.1055/s-0030-1267854
Oppenheimer J, Ray CE, Kondo KL. Miscellaneous pharmaceutical agents in interventional radiology. Semin Intervent Radiol. 2010 Dec;27(4):422-30. doi: 10.1055/s-0030-1267854. PMID: 22550384; PMCID: PMC3324198.
Copy Download .nbib Format: NLM
Showing 13 to 21 of 21 entries